Direct Connect

Connecting patients direct to a study website.

Direct Connect lets you tap into SubjectWell’s unmatched patient access.

Millions of people search our patient website to find active studies.

SubjectWell’s machine learning guides patients to your trial information based on their known conditions and study-appropriate geographies. Motivated patients select your trial and connect directly to a study website for registration and prescreening.

Faster enrollment without sacrificing quality.

Extend your reach to find new patients — the 91% of patients who have never participated in a clinical trial before. We present your study to our patients with known conditions, sourced from nontraditional recruitment channels.

SubjectWell's unique approach delivers more interested patients.

SubjectWell finds motivated patients through general awareness advertising.

Patients registering in SubjectWell’s marketplace share their conditions and interest in treatment.

Advanced machine learning presents relevant trial listings to patients, by condition and location.

Interested patients follow the customized pipeline from SubjectWell to your study’s website.

We complement your study's marketing and infrastructure.

Use your study-specific materials and resources.

SubjectWell sends quality patients directly to your recruitment funnel, leveraging your investment in a study-specific website.

We’ll build and host a pre-screening landing page for you.

SubjectWell can create the pre-screener based on your protocol and build a custom web form for your study, to ensure your direct referrals are qualified.

Track recruitment metrics with a customized pipeline.

With SubjectWell’s Performance Portal, sponsors and CROs get access to a real-time view of the anonymized patients sent to your study’s website, as well as the patients’ actions on the site. And when using SubjectWell’s hosted pre-screener, sites and sponsors get patient referral counts and the ability to track the patients’ progress through the enrollment process.